Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients
Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the synergistic anti-tumor effect of ChangTai Keli based
on chemotherapy for colon cancer patients by a randomized, parallel-group, double-blind,
multicenter clinical study.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Nanjing NingQi Medicine Science and Technology Co., Ltd.
Collaborator:
Jiangsu Province Hospital of Traditional Chinese Medicine